Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ESR1 | P03372 | 11/20 | 0.71 |
| ▸ | ESR2 | Q92731 | 8/20 | 0.67 |
| ▸ | SHBG | P04278 | 4/20 | 0.60 |
| ▸ | HSD17B10 | Q99714 | 4/20 | 0.60 |
| ▸ | LMNA | P02545 | 4/20 | 0.60 |
| ▸ | STS | P08842 | 3/20 | 0.60 |
| ▸ | PGR | P06401 | 3/20 | 0.60 |
| ▸ | SERPINA6 | P08185 | 3/20 | 0.60 |
| ▸ | AR | P10275 | 3/20 | 0.60 |
| ▸ | SLC6A4 | P31645 | 3/20 | 0.60 |
| ▸ | SNCA | P37840 | 3/20 | 0.60 |
| ▸ | SLC6A3 | Q01959 | 3/20 | 0.60 |
| ▸ | HIF1A | Q16665 | 3/20 | 0.60 |
| ▸ | HSD17B1 | P14061 | 2/20 | 0.60 |
| ▸ | AKR1B10 | O60218 | 2/20 | 0.60 |
| ▸ | CYP1A2 | P05177 | 2/20 | 0.60 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.60 |
| ▸ | MAPT | P10636 | 2/20 | 0.60 |
| ▸ | AKR1B1 | P15121 | 2/20 | 0.60 |
| ▸ | HTR2B | P41595 | 2/20 | 0.60 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL10771941 | 0.84 | ESR1 (0.80) | ESR1ESR2SHBGHSD17B10LMNA | |
| SCHEMBL7057452 | 0.82 | ESR1 (0.76) | ESR1ESR2SHBGHSD17B10LMNA | |
| SCHEMBL5677986 | 0.82 | ESR1 (0.76) | ESR1ESR2SHBGHSD17B10LMNA | |
| SCHEMBL5159033 | 0.82 | ESR1 (0.71) | ESR1ESR2SHBGHSD17B10LMNA | |
| SCHEMBL7218327 | 0.82 | ESR1 (0.71) | ESR1ESR2SHBGHSD17B10LMNA | |
| SCHEMBL2833353 | 0.81 | ESR1 (0.58) | ESR1ESR2LMNACYP19A1SMN1; SMN2 | |
| SCHEMBL7058461 | 0.81 | ESR1 (0.83) | ESR1ESR2SHBGHSD17B10LMNA | |
| SCHEMBL18244641 | 0.81 | ESR1 (1.00) | ESR1ESR2SHBGHSD17B10LMNA | |
| SCHEMBL5156065 | 0.80 | ESR1 (0.71) | ESR1ESR2SHBGHSD17B10LMNA | |
| SCHEMBL8436829 | 0.80 | ESR1 (0.71) | ESR1ESR2SHBGHSD17B10LMNA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 12 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-0830369-B1 | NOR-PREGNANES FOR INDUCING HYPOTHALAMIC EFFECTS | PHERIN PHARM INC (US) | 2003-05-14 | — | — | EP | claimed |
| EP-0830369-B1 | NOR-PREGNANES FOR INDUCING HYPOTHALAMIC EFFECTS | PHERIN PHARM INC (US) | 2003-05-14 | — | — | EP | disclosed |
| US-6331534-B1 | ADMINISTERING EFFECTIVE AMOUNT OF STEROID WITHIN NASAL PASSAGE OF INDIVIDUAL SUCH THAT IT BINDS SPECIFICALLY TO RECEPTORS ON SURFACE OF NASAL NEUROEPITHELIAL CELLS IN VOMERONASAL ORGAN | PHERIN PHARMACEUTICALS, INC. | 2001-12-18 | — | — | US | disclosed |
| US-6242619-B1 | BEHAVIORAL OR PHYSIOLOGICAL RESPONSE, REDUCTION OF NEGATIVE AFFECT, MOOD, AND CHARACTER TRAITS; NASAL ADMINISTRATION OF VOMEROPHERINS OR PHEROMONES, NERVOUS SYSTEM DRUG MODE | PHERIN PHARMACEUTICALS, INC. | 2001-06-05 | — | — | US | disclosed |
| US-6117860-A | NASALLY ADMINISTERING STEROID WHICH BINDS TO A SPECIFIC NEUROEPITHELIAL RECEPTOR FOR ALLEVIATING PREMENSTRUAL TENSION AND ANXIETY | PHERIN PHARMACEUTICALS, INC. (US) | 2000-09-12 | — | — | US | disclosed |
| US-6066627-A | ALTERING BLOOD CONCNETRATION OF LUTEINIZING HORMONE | PHERIN CORPORATION (US) | 2000-05-23 | — | — | US | disclosed |
| US-6057439-A | EPOXYSTEROIDS | PHERIN CORPORATION (US) | 2000-05-02 | — | — | US | disclosed |
| US-5962443-A | 19-nur-pregnane steroids as neurochemical initiators of change in human hypothalamic function | PHERIN CORPORATION (US) | 1999-10-05 | — | — | US | disclosed |
| EP-0830369-A4 | NOVEL NOR-PREGNANES FOR INDUCING HYPOTHALAMIC EFFECTS | PHERIN PHARM INC (US) | 1999-06-09 | — | — | EP | disclosed |
| US-5792757-A | ANTIFERTILITY AGENTS, ANXIOLYTIC AGENTS | PHERIN PHARMACEUTICALS (US) | 1998-08-11 | — | — | US | disclosed |
| EP-0830369-A1 | NOVEL NOR-PREGNANES FOR INDUCING HYPOTHALAMIC EFFECTS | Pherin Pharmaceuticals, Inc. (US) | 1998-03-25 | — | — | EP | disclosed |
| WO-1996040727-A1 | NOVEL NOR-PREGNANES FOR INDUCING HYPOTHALAMIC EFFECTS | PHERIN PHARMACEUTICALS, INC. (US) | 1996-12-19 | — | — | WO | disclosed |